Method of optimizing the treatment of proliferative diseases mediated by the tyrosine kinase receptor KIT with imatinib
US-9763944-B2 · Sep 19, 2017 · US
Wang Yanfeng holds 9 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 9 |
| Recent patents | 0 |
| First publication | May 12, 2015 |
| Latest publication | Sep 19, 2017 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-9763944-B2 · Sep 19, 2017 · US
US-2017035757-A1 · Feb 9, 2017 · US
US-2017007605-A1 · Jan 12, 2017 · US
US-9312358-B2 · Apr 12, 2016 · US
US-2016045501-A1 · Feb 18, 2016 · US
Representative or frequently cited publications from precomputed assignee stats.
US-9763944-B2 · Sep 19, 2017 · US
US-2017035757-A1 · Feb 9, 2017 · US
US-2017007605-A1 · Jan 12, 2017 · US
US-9312358-B2 · Apr 12, 2016 · US
US-2016045501-A1 · Feb 18, 2016 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P35/02 | 4 |
| A61K31/506 | 4 |
| A61P35/00 | 3 |
| A61P35/04 | 3 |
| A61P43/00 | 3 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Electricity | 5 |
| Human Necessities | 4 |
| Physics | 4 |